Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03330197
Title A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors or DIPG
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ziopharm

brain stem cancer

brain cancer


Ad-RTS-IL-12 plus AL

Age Groups: child | adult
Covered Countries USA

No variant requirements are available.